NEW YORK (GenomeWeb News) – Actar, a part of the Karolinska Institutet innovations system in Sweden, has purchased Corning’s Epic System, which it will use in providing label-free drug screening services.
 
According to Corning, Actar is the first and only company to offer high-throughput, label-free drug screening to academic researchers in Scandanavia and Europe on a fee-for-service basis.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.